TrialJournal of hematology & oncology2025

WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome.

Zwi N Berneman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.